A Single Blind, Single Arm Clinical Trial to ascertain the effect of Homoeopathic Medicines in arresting the pathogenesis of disease in asymptomatic Corona virus and suspected Corona virus Patients
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Primary endpoint of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or appearance of symptoms where conventional treatment starts
研究概览
简要总结
Theprimary aim of this study is to assess the effect of Homoeopathic treatment inarresting the pathogenesis of disease in asymptomatic infected corona viruspatients as well as suspected patients who are placed in quarantine. We willalso evaluate the time of recovery of such patients after Homoeopathicintervention. In cases where symptoms do appear after the intervention, timetaken to reach that stage will be evaluated in order to study the effect ofHomoeopathic intervention during this stage of the pathogenesis of the disease.Suspected patients who are not confirmed Corona virus positive, waiting for thetest results but are placed in quarantine will also be given Homoeopathicmedicine under this trial and the test results will be evaluated thereafter tostudy the effect of Homoeopathic treatment for such patients.
Effective Homoeopathic treatment forthis section of patients can be a game changer in this pandemic since it mayprove to be a vital treatment against corona virus infection when it is inearly stage of pathogenesis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 5.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •â€¢Asymptomatic patients confirmed positive with COVID-19 tests criteria will be included.
- •â€¢Suspected corona virus patients who are quarantined will also be included.
- •â€¢Patients with age groups of 5-70 years.
- •â€¢Patients who are willing to give informed consent for treatment.
排除标准
- •â€¢Symptomatic patients confirmed positive with COVID-19 tests criteria will be included.
- •â€¢More than 70 years of age and less than age of 5 years.
- •â€¢Subjects considered not suitable for the study by the researchers.
结局指标
主要结局
Primary endpoint of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or appearance of symptoms where conventional treatment starts
时间窗: 21 days
次要结局
- Improvement in the quality of life w.r.t. activity, appetite, sleep and general condition of the patient.(4 days)
- Suspected cases in quarantine confirmed as negative(14 days/ until discharge)